Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
60.5M
-
Number of holders
-
194
-
Total 13F shares, excl. options
-
63.5M
-
Shares change
-
+2.68M
-
Total reported value, excl. options
-
$956M
-
Value change
-
+$12.8M
-
Put/Call ratio
-
0.31
-
Number of buys
-
107
-
Number of sells
-
-70
-
Price
-
$15.08
Significant Holders of Twist Bioscience Corp - Common Stock (TWST) as of Q1 2023
237 filings reported holding TWST - Twist Bioscience Corp - Common Stock as of Q1 2023.
Twist Bioscience Corp - Common Stock (TWST) has 194 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.5M shares
.
Largest 10 shareholders include ARK Investment Management LLC (7.18M shares), BlackRock Inc. (6.21M shares), VANGUARD GROUP INC (5.7M shares), STATE STREET CORP (5.28M shares), JPMORGAN CHASE & CO (4.06M shares), Nikko Asset Management Americas, Inc. (3.4M shares), Sumitomo Mitsui Trust Holdings, Inc. (3.4M shares), FMR LLC (2.65M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (2.05M shares), and CREDIT SUISSE AG/ (1.45M shares).
This table shows the top 194 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.